NEU

15.1%

$16.57 neuren pharmaceuticals limited

Updated MST report - target of $3.68 a share, page-205

First 205 Last

Share
Profile

Follow
perthpest

564 Posts.

53

18/03/23

10:56

Post #: 66836931
Share

Originally posted by Taureanbull: ↑

Perthpest,

Good post. Remember what Shire Pharmaceuticals did with Orphan Drugs a few years back.

If we were Nasdaq Listed we wouldn’t be wallowing down here at $2.22. Your valuation comes out at $132 per share. Sounds crazy but we have all seen Nasdaq companies have moves like this with successful trials.

And that’s not including our 5 other indications. This isn’t like the old days when a biotech tried to cure diseases with random small molecule drugs they found in venomous animals or rainforests etc. The knowledgeable scientists progressing both our drugs have a very good idea what to expect. As Jon Pilcher just said the pre-clinical studies for 2591 have extraordinary results.

NEU is only 12 months from Ph2 results for 4 more indications. If they were to prove successful a certain value would have to be attributed to the possible success of even more indications. Is NEU currently doing pre-clinical work in more diseases. Are any any of the many companies that NEU are in discussions with, offering partnerships and money to pursue the big issues, Dementia,Autism,Parkinsons and Huntington’s ??!???

Now that the ASX market has had a taste of Nasdaq style success with Afterpay , Atalassian and others, punters will be keen for more high tech global winners. Post Ph3 results NEU will be front page of Financial Press.

I really do think many investors have a bad relationship ship with money, they are afraid of success and don’t believe they deserve to win big time. They don’t date to dream big. To my mind that’s why most people don’t get really wealthy. Most people don’t ever achieve wealth because they can’t overcome the mindset of hard work and frugality., This work is awash with money. It’s never been easier to earn immense wealth.

All an investor has to do , is trawl the stock market and find tomorrow’s winners. They are in by people with big dreams, courage and tenacity. NEU is one of those stories. 30 years of science and hard work.

The number companies that will be big winners is growing as the digital revolution keeps progressing. NEU will take part as the interconnected sufferers and caters keep abreast of our progress. It won’t take years to boost sales. We’ve got Orphan Status.

Only 12 months to go in this long journey, however our shareprice has started its climb now.

Expand

Good to remember some of the older chit chat on valuations and how an acquisition might work

NEU Price at posting: $13.23 Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

Week 45 Wrap: Combat sports usher in Trump 2.0 – or is it male insecurity?; RBA boring; Propane suggests China alive

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

HotCopper Highlights: Your most watched and most discussed stocks this week

FG1

Flynn Gold reaches milestone exploration target for Golden Ridge

UBI

Universal Biosensors flat despite fresh deal with US medical product distributor

IMU

Imugene kicks off Australian trial for blood cancer treatment

Trump is President Again: What Does This Mean for Crypto?

MMI

Metro Mining inks bauxite offtake contracts into 2026 with Chinese m

Trump Victory Sends Bitcoin Surging Above $75K – Is $100K Next?

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

First 205 Last

Add NEU (ASX) to my watchlist

(20min delay)
Last $16.57		Change 2.170(15.1%)		Mkt cap ! $2.117B

Open	High	Low	Value	Volume
$14.85	$16.67	$14.60	$24.77M	1.544M

Buyers (Bids)

No.	Vol.	Price($)
1	1500	$16.52

Sellers (Offers)

Price($)	Vol.	No.
$16.57	1717	1

View Market Depth

No.	Vol.	Price($)
1	1500	16.520
2	400	16.480
1	300	16.470
2	1367	16.440
2	5242	16.400

Price($)	Vol.	No.
16.570	1717	1
16.590	1367	2
16.600	4715	3
16.620	2306	2
16.650	2000	1

Last trade - 16.10pm 08/11/2024 (20 minute delay)

NEU (ASX) Chart

Updated MST report - target of $3.68 a share, page-205

Week 45 Wrap: Combat sports usher in Trump 2.0 – or is it male insecurity?; RBA boring; Propane suggests China alive

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

HotCopper Highlights: Your most watched and most discussed stocks this week

Flynn Gold reaches milestone exploration target for Golden Ridge

Universal Biosensors flat despite fresh deal with US medical product distributor

Imugene kicks off Australian trial for blood cancer treatment

Trump is President Again: What Does This Mean for Crypto?

Metro Mining inks bauxite offtake contracts into 2026 with Chinese m

Trump Victory Sends Bitcoin Surging Above $75K – Is $100K Next?

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Updated MST report - target of $3.68 a share, page-205

Top Stories

Week 45 Wrap: Combat sports usher in Trump 2.0 – or is it male insecurity?; RBA boring; Propane suggests China alive

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

HotCopper Highlights: Your most watched and most discussed stocks this week

Flynn Gold reaches milestone exploration target for Golden Ridge

Universal Biosensors flat despite fresh deal with US medical product distributor

Imugene kicks off Australian trial for blood cancer treatment

Trump is President Again: What Does This Mean for Crypto?

Metro Mining inks bauxite offtake contracts into 2026 with Chinese m

Trump Victory Sends Bitcoin Surging Above $75K – Is $100K Next?

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News